Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen
Clinical trial NCT07055295 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07055295
- Sponsor
- Sinovac Biotech Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2026-12-30
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.